ElisaFerracane

575 posts

ElisaFerracane

ElisaFerracane

@ElisaFerracane

Words, words, words.

Katılım Mart 2008
106 Takip Edilen119 Takipçiler
ElisaFerracane retweetledi
Zachary Lipton
Zachary Lipton@zacharylipton·
Evaluation of ambient scribes is a formidable task due to the free-form nature of generated text. Rigor requires automated metrics, strong benchmarks, clinician-in-loop trials, and in vivo testing. Learn how we're tackling these challenges at @AbridgeHQ: abridge.com/ai/science-ai-…
English
2
18
61
14.5K
ElisaFerracane retweetledi
EMNLP 2026
EMNLP 2026@emnlpmeeting·
The D&I subsidy call for #EMNLP2024 is now available: 2024.emnlp.org/calls/subsidie… Subsidies available for registration, caregiving, bandwidth, travel and VPN! See website for more details. Deadline is Friday, October 11th 11:59 (AOE)
English
2
17
38
15.2K
ElisaFerracane retweetledi
Nikhil Krishnan
Nikhil Krishnan@nikillinit·
new post - we took a look at behind the technical curtain some of the interesting engineering challenges behind a company (@AbridgeHQ ) training their own LLMs. -dealing with multiple languages -handling model drift -generalist models vs. healthcare specific ones and more (just fyi, this one is a sponsored post but it's pretty interesting if you're interested in healthcare-specific LLMs)
Nikhil Krishnan tweet media
English
2
5
19
5.6K
ElisaFerracane
ElisaFerracane@ElisaFerracane·
If I didn’t catch you at ACL, reach out to me here to talk about our research!
Abridge@AbridgeHQ

Two of our brilliant team members, Davis Liang and Elisa Ferracane, represented Abridge at ACL 2024 in Bangkok, showcasing research that pushes the boundaries of Natural Language Processing (NLP) and multilingual understanding. 🌎🌟 Davis Liang, a Staff Research Scientist at Abridge, presented Belebele, a multilingual reading comprehension dataset covering 122 language variants designed to tackle the global challenge of understanding text across diverse languages. This dataset enables direct comparison of how well models understand different languages and opens new possibilities for evaluating and discussing LLM multilinguality: aclanthology.org/2024.acl-long.… Elisa Ferracane, a Senior NLP Research Scientist at Abridge, in collaboration with lead author Sanjana Ramprasad, an Abridge research intern, shared cutting-edge research on tackling hallucination errors in LLMs, particularly in dialogue summarization. Their work introduced a new error category to better address these challenges, marking a crucial step forward as LLMs evolve: aclanthology.org/2024.acl-long.… We’re proud to have these pioneers driving innovation at Abridge, where their expertise guides us as we build the most advanced AI platform for clinical documentation. Congrats, Davis, Elisa, and Sanjana for all your outstanding work! 👏

English
0
0
3
165
ElisaFerracane
ElisaFerracane@ElisaFerracane·
Headed to ACL? Let’s talk about factuality and summarization, especially in the domain of conversations. DM me here or on Whova. You can also find me at the Tuesday morning poster session, presenting our paper with @sanjana_rampi. arxiv.org/abs/2406.03487 #ACL2024NLP
English
0
2
11
637
ElisaFerracane
ElisaFerracane@ElisaFerracane·
Focusing on one of my favorite domains of conversations, where so much is left unsaid, @sanjana_rampi shares lots of insights on understanding and identifying hallucinations in summaries:
Sanjana Ramprasad @ NeurIPS2025@sanjana_rampi

Check out our #ACL2024NLP paper benchmarking LLMs for faithfulness on dialogue summarization. Our analysis highlights hallucination subtleties and introduces a new error category to capture LLM-specific behavior 🧵👇 arxiv.org/abs/2406.03487 w/ @ElisaFerracane @zacharylipton

English
0
0
0
397
ElisaFerracane
ElisaFerracane@ElisaFerracane·
@ReviewAcl We have an issue with the author list for our ARR submission which is now accepted to ACL 2024. Can you please help? (We've tried emailing both arr and acl mailing lists with no response).
English
0
0
0
152
ElisaFerracane
ElisaFerracane@ElisaFerracane·
@ReviewAcl Please allow for smaller max load in the review form. I am a careful reviewer and unable to commit to reviewing 4 papers. I feel this policy targets and excludes researchers who are already being marginalized due to lack of resources. @thamar_solorio @annargrs
English
1
0
5
206
ElisaFerracane
ElisaFerracane@ElisaFerracane·
A testament to our mission and our people at Abridge 💚
Abridge@AbridgeHQ

📣 Today, we are announcing our $150M Series C! This is one of the largest funding rounds made to date in generative AI for healthcare. We are grateful to the luminary investors and iconic institutions who believe in us and our mission—to power deeper understanding in healthcare. This round was led by @lightspeedvp who will be joining our board. Other new and existing investors joining the round include co-lead @Redpoint, with support from @IVP, @sparkcapital, @usv, @BessemerVP, @WittingtonVC, Mass General Brigham Artificial Intelligence and Digital Innovation Fund (AIDIF), Kaiser Permanente Ventures, and CVS Health Ventures. With this new capital, we will continue to push boldly into fundamental research, developing bedrock foundation models that draw upon vast troves of multimodal healthcare data. Looking forward to this new wave of possibilities as we continue to fulfill our vision of improving the lives of patients and clinicians. Read more about our Series C here: abridge.com/press-release/…

English
0
0
6
467
ElisaFerracane retweetledi
Zachary Lipton
Zachary Lipton@zacharylipton·
The #MLHC2023 #runconference leaving at 6:45a (in 10m) from the lobby of Hotel Belleclaire! Join us today and/or tomorrow.
English
1
1
11
7K
ElisaFerracane retweetledi
NYT Business
NYT Business@nytimesbusiness·
ChatGPT-style artificial intelligence is coming to health care, and the grand vision of what it could bring is inspiring. nyti.ms/3JvZc2x
English
1
5
19
28.1K